<SEC-DOCUMENT>0001193125-17-280655.txt : 20170908
<SEC-HEADER>0001193125-17-280655.hdr.sgml : 20170908
<ACCEPTANCE-DATETIME>20170908163357
ACCESSION NUMBER:		0001193125-17-280655
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20170906
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20170908
DATE AS OF CHANGE:		20170908

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Precipio, Inc.
		CENTRAL INDEX KEY:			0001043961
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				911789357
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36439
		FILM NUMBER:		171076932

	BUSINESS ADDRESS:	
		STREET 1:		12325 EMMET ST
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164
		BUSINESS PHONE:		4027385480

	MAIL ADDRESS:	
		STREET 1:		12325 EMMET STREET
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRANSGENOMIC INC
		DATE OF NAME CHANGE:	20000119
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d425505d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>WASHINGTON, D. C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO SECTION 13 OR 15(d) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>OF THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of report (Date of earliest event reported): September&nbsp;6, 2017 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>PRECIPIO, INC. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact
Name of Registrant as Specified in Its Charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">001-36439</FONT></B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">91-1789357</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>(State of Incorporation)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification No.)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>4 Science Park, New Haven, CT 06511 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices) (Zip Code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(203) <FONT STYLE="white-space:nowrap">787-7888</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Not Applicable </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former
name, former address and former fiscal year, if changed since last report date) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below
if the Form <FONT STYLE="white-space:nowrap">8-K</FONT> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule <FONT STYLE="white-space:nowrap">14a-12</FONT> under the Exchange Act (17 CFR <FONT STYLE="white-space:nowrap">240.14a-12)</FONT> </TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">14d-2(b)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.14d-2(b))</FONT> </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#9744;</TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="white-space:nowrap">Pre-commencement</FONT> communications pursuant to Rule <FONT STYLE="white-space:nowrap">13e-4(c)</FONT> under the Exchange Act (17 CFR
<FONT STYLE="white-space:nowrap">240.13e-4(c))</FONT> </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 or Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Securities Exchange Act of 1934. </P> <P STYLE="margin-top:0pt;margin-bottom:0pt;page-break-before:always"></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a) of the Exchange
Act.&nbsp;&nbsp;&#9744; </P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;7.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Regulation FD Disclosure. </B></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On September&nbsp;6, 2017, Precipio, Inc. (the
&#147;<U>Company</U>&#148;) issued a press release, which included a letter to shareholders from the Company&#146;s Chief Executive Officer, Ilan Danieli. As noted in the press release, management will host a business update conference call to
discuss recent corporate developments and strategic initiatives on Tuesday, September&nbsp;12, 2017, at 4:30pm Eastern Time. The press release is furnished as Exhibit 99.1 and incorporated herein by reference. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information in this Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> furnished under this Item&nbsp;7.01 shall not
be deemed &#147;filed&#148; for any purpose, including for the purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &#147;<U>Exchange Act</U>&#148;), or otherwise subject to the liabilities of that Section.
Furthermore, the information in this Current Report on <FONT STYLE="white-space:nowrap">Form&nbsp;8-K</FONT> furnished under this Item&nbsp;7.01 shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as
amended, or the Exchange Act regardless of any general incorporation language in such filing. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">Exhibits. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00pt solid #000000; width:25.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>No.</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; width:39.50pt; font-size:8pt; font-family:Times New Roman"><B>Description</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d425505dex991.htm">Press Release of Precipio, Inc. dated September&nbsp;6, 2017 </A></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>PRECIPIO, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Ilan Danieli</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Ilan Danieli</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Chief Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: September 8, 2017</P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d425505dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g425505g0908074646134.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Precipio Provides Shareholder Update Letter </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>NEW HAVEN, Conn., (September 06, 2017) &#150; </B>Precipio, Inc. (NASDAQ: PRPO), today released the following Letter to its Shareholders: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Valued Shareholders, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As we enter the second half of 2017,
I am delighted to report that we reached the end of a long process that began almost a year ago, culminating in the recent merger of Precipio with Transgenomic and our relisting on NASDAQ. I was very proud to stand with my team and my shareholders
and represent them in ringing the NASDAQ opening bell. With our new listing and recent financings, we believe we are in a strong position to grow our business. We intend to focus on executing our vision to eradicate the misdiagnosis of serious
diseases such as cancer, through our unique platform and laboratory focused on delivering specialized diagnostic services to physicians and their patients. We believe physicians and their patients can greatly benefit from access to the expertise and
technologies within academic institutions our platform provides. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Developments </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Consolidated Laboratory Operations </I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Since the
merger was announced, our challenge of combining both businesses was formidable. One of the largest operating expenses for Transgenomic was the operations of the laboratory in Omaha, Nebraska. Transgenomic leased a 30,000 sq. foot facility which
housed both its CLIA laboratory testing facility, as well as an R&amp;D facility. We took the pending merger as an opportunity to negotiate a settlement with the landlord that would allow the company to move to a smaller facility more suitable for
its needs, and at a far lower cost. Precipio operates its own CLIA facility in New Haven, CT, and upon the merger, had planned to consolidate its two CLIA operations into one facility. The transition of the Transgenomic CLIA laboratory to New Haven
is a significant operational undertaking which involved major steps including shutting down the lab operations, relocating all equipment to the New Haven facility, setting up the laboratory, the integration with the existing laboratory operations,
equipment <FONT STYLE="white-space:nowrap">re-validation</FONT> etc. and finally resuming operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We began this process in June and expect to
complete it in September. We anticipate the backlog that accumulated during the transition will be completed by end of year; we will be resuming existing projects, and have also received new projects from a number of our customers. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Reducing Accounts Payable </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of the consolidation of our two entities, over the past few months we have successfully negotiated reduced balances on a significant part of the
accounts payable. The payments will be made from proceeds from our recently completed offering, with the majority of amounts being paid down over the next <FONT STYLE="white-space:nowrap">12-18</FONT> months. The settlement agreements signed with
the vendors generally stipulate that once the settlement payments have been made in full, the settlement is completed. At that time, the company will be eligible to write down the remaining balance of the paid account to zero. Therefore, while the
full amount will not be written off and reflected in our financials for another year, the actual outlay required to satisfy the accounts payable balance is significantly lower. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The challenge of combining these businesses is formidable, but we believe this process was necessary for creating long- term value for our shareholders. Once
completed, our operations will be centralized and streamlined with better resources to enable us to execute our vision. In fact, we will be a leaner and more competitive company. As we previously announced, we have already reduced our combined burn
rate by more than $5M on an annualized basis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Therefore, it is with great pride and a strong sense of purpose and responsibility, that we proceed in our
efforts to grow the business. We&#146;d like to thank you for your continued encouragement and support as we work to carry Precipio forward through the next phases of our development and growth. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Sincerely, </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ilan Danieli </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Executive Officer </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Precipio, Inc. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Business Update Conference Call </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management will host a
business update conference call to discuss recent corporate developments and strategic initiatives on Tuesday September&nbsp;12, 2017, at 4:30pm Eastern Time. Following management&#146;s formal remarks, there will be a question and answer session.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To listen to the conference call, interested parties within the U.S. should call <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1-877-317-6789.</FONT></FONT></FONT> International callers should call <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-412-317-6789.</FONT></FONT></FONT> All callers
should ask for the Precipio Corporate Update conference call. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Precipio </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Precipio has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic
institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, initially the Yale
School of Medicine, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more information, please visit www.precipiodx.com. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Certain statements in this
press release constitute &#147;forward-looking statements,&#148; within the meaning of federal securities laws, including statements related to Precipio&#146;s merger with Transgenomic, consolidation of laboratory operations, reductions of accounts
payable, plans and prospects and other statements containing the words &#147;anticipate,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;predict,&#148; &#147;will,&#148; &#147;would,&#148; &#147;could,&#148; &#147;should,&#148;
and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The Company&#146;s actual results could differ materially from those anticipated in these forward-looking
statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the known risks, uncertainties and other factors described in
the Company&#146;s definitive proxy statement filed on May&nbsp;12, 2017, the Company&#146;s Quarterly Report on Form <FONT STYLE="white-space:nowrap">10-Q</FONT> for the quarter ended June&nbsp;30, 2017, the Company&#146;s prior filings and from
time to time in the Company&#146;s subsequent filings with the Securities and Exchange Commission. Any change in such factors, risks and uncertainties may cause the actual results, events and performance to differ materially from those referred to
in such statements. All information in this press release is as of the date of the release and the Company does not undertake any duty to update this information, including any forward-looking statements, unless required by law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contacts: </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Precipio Investor Relations: </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">John Marco </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Managing Director </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Core IR </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">377 Oak Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Garden City, NY 11530 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">516 222 2560 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">johnm@coreir.com </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">www.coreir.com </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g425505g0908074646134.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g425505g0908074646134.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !- 9,# 2(  A$! Q$!_\0
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MHQ)! /;BLK_A6'A'_H%+_P!_&_QKKZ*A3DE9,+(Y#_A6'A'_ *!2_P#?QO\
M&HKCX5^$YH2B6#0L>CQR-D?K7:44_:3[A9'D<+ZG\+O$5K;7%U)=^';U]BLY
MYB/]"/U%>LO@Q,<Y!6N ^,C0CP2J/CSFND\H=\\Y_2NTTU9%T.T67/F"V0/G
MKG:,U4_>BI=06]CRCX:>%-%U_3M3FU.Q2>2*\9$))X&,XKN?^%:^$O\ H$1_
M]]&L#X-?\@?6/^O]OY"O2Z=6<E-V8DE8Y/\ X5KX2_Z!$?\ WT:/^%:^$O\
MH$1_]]&NLHJ.>7<=D<JGPX\*1R*ZZ1%N4@C)/45U5%%2Y-[L9E>(/$%CX;TJ
M34+^3"+PB#[TC=@*\[M['Q9\1S]JO;I])T5CF.&/AI!_7ZFG^3_PL/XE7"SD
MOHNBG:$_AD?/]2#^ KU555%"J J@8  X%:_PUIN+<XBS^%'A:WC FM9+E^[R
MRG-6?^%8^$?^@4O_ 'VW^-=?14>TGW"R./\ ^%8>$?\ H$K_ -]M_C76)$D-
MLL4:A8T3:JCL .*DI&^XWTJ7)O=C2/-_@Y_R"=:_["#?R%=7K7@[0O$%VMUJ
M=BLTRIL#[B#C\*Y3X.?\@G6O^P@W\A7I-:56U4;1*V.0_P"%8>$?^@4O_?QO
M\:/^%8>$?^@4O_?QO\:Z^BI]I/N.R.(N_A3X5N("D5F]N_:2.0Y%<_H]YJOP
M\\56V@ZI<M=:-?-MMIW/^K/0?3G (]\UZO7FGQC,9TK1XEYNVOE,0'7&.?U*
MU=.3D^66J8FK:H](D_U3_P"Z:\Y^#7_(OZK_ -A%_P#T%:]$^86N'^]LY^N*
M\[^#7_(OZK_V$7_]!6IC\$OD-[H]'D=8XVD=@J*,LQ. !ZUYAJ'BO7?&>J2Z
M1X0!@LXCMGU!N/R/;^=7OBAJMTZ:?X7TYB+O59 KD'D1YQ^I_0&NO\/Z%:>'
M-'@TZS0!8Q\[8Y=N[&FK0CS/<-]#D=/^$FCIB75KBYU&Y/+M(Y"D_2K]Q\+/
M"<T95=/,3=GCD8$?K79T5+J3[A9'E5UX3\2^"2U_X8U"6\LT^:2RFY)'L._\
MZ[+PCXOL_%FG&6$>3=1<3V['E#_A71UY5XRLV\$>+;'Q9IR[+6XD\J^B7H<]
M3^(_45:?M-'N&QZK13(I$FB26-@R.H92.X/2BL1CZQKKQ7H5E=R6EUJEO#/&
M<.CM@BMFOG+XH6WV?X@ZB2O$HCD'OE!_4&M:4%.5F*3LCW(>+_#S=-8M/^_E
M7;'6=-U.1H[*]AN'0;F6-LD#UKY0P/05WWPAOTLO&I@<A1>6[1#W888#]#6L
M\.E%M,E3NSWQXTE0I(BNIZAAFN>O?!FG33K=6>^RNE.Y9(3C!^E=)17%*$9;
MH)PC/XD5K(72VX2\9'E7@NG ;WQVJS115)61:T*FJVZ7>D7EO(,K)"ZG\0:^
M;1P,'M7T=K=XEAH=]=.<+%"Q_'''ZU\Y#..>M>C@KV9A6Z'0>")FA\::6RG&
MZ4H?H017OE>"^!;=KCQIIH ^XYD/T"DU[U66,^->A5'X2IJ6H0:5IMQ?W3$0
M6Z%W(&3@5Q(^,'AXC(BO"/:*N@\=C/@76?\ KV:LWX;V5I+\/])>2UA=RCY9
MHP2?G:L8J*CS,T=[E'_A;_A__GC>_P#?DT?\+?\ #_\ SQO?^_1KN/[.L?\
MGSM_^_2_X4?V=8_\^=O_ -^E_P *5Z?8-3S'5/&FL^,XVTCPQIMQ#'.-DMW*
M,;5/7GM7>>%/#L'A?0(=-A.]A\\LG]]SU-;$<,4*[8HT1?15 %/I2G=62L@2
M.:\3>-M*\*W%O!?^<TDZET6-,\ XK#_X6_X?_P">-[_WY-4?'"*_Q4\(*ZAE
M;(((R#\U>C?V=8_\^=O_ -^E_P *JT(Q5UN&IP__  M_P_\ \\;W_OR:;+\8
M-$"'R+.^ED[((\9KNO[.L?\ GSM_^_2_X5QOB/7U\->+])M[C3K1='O%V-/Y
M0W+)GU]!Q3CR2=DOQ%J8NG:5K7Q \0VVLZ[;-9Z1:-NM[5NKGZ?S->IO_JV^
MAI1C QT[4DG^K;Z&LY2YAI6/+_A1=QV'AG7[R4,8X+MY&"C)P%SP*O?\+AT/
M_GSOO^_=0?!P!M&U@$ @WS @_05Z%_9]E_SYV_\ WZ7_  K6HXJ;NA*]CA/^
M%PZ'_P ^=]_W[K7\._$'3/$NJ?V?:P74<I0N#)'@8'O72?V?9?\ /G;_ /?I
M?\*DBM;>!MT4$4;$8RB &H;A;1#U):@OI3!87,PZQQ,P_ $U/4<\0F@DB;[K
MJ5/XBLQGGWP:@ \)7-X>9;F\<N?7 '_UZ]%KS3X1W!L[?6/#TYVW%C=LVT]2
MIX)_,?K7I=:5?C8H[!11168PI&^XWTI:1ON-]* /-_@Y_P @G6O^P@W\A6_X
MC\?:/X9U%+&\$[3M&),1IG /3^58'P<_Y!.M?]A!OY"H-8C27XZZ2DB*Z-:'
M*L,@_*]=$HIU'<E;%_\ X6_X?_YXWO\ WY-'_"W_  __ ,\;W_OR:[C^SK'_
M )\[?_OTO^%']G6/_/G;_P#?I?\ "L[T^P]3@YOB_H_ED6EC?3S'[J>7C)JK
MX?T/6?%OB>'Q/XCA^SVUMS9VA[>AQ^OO7HZV-FC!DM(%8="(P#5BCG27NH+=
MQDG^J?\ W37G/P:_Y%_5?^PB_P#Z"M>CR?ZI_P#=-><?!K_D7]5_["+_ /H*
MT1^"7R![H8%^W?'IA)RME8[HP>QVC_XLUZ97F.M/_8/QITO49CMM]1M_(+'H
M&QMQ^>W\Z].HJ=/0$%%%%9C"N4^)5JEU\/\ 50X!\N,2+[%6!KJZX?XKZFEC
MX(N+8']]>NL$:]SSD_H/UJZ?QJPGL:_@6X>Z\#:--(<L;902?;C^E%6_#&GM
MI7A?3+%QAX;=%8>AQD_K12E\3L-&M7CGQJT=ENM/UE%^1U-O*1V(Y7^M>QUD
M^)-#A\1Z#=:9-@>:OR/_ '''*G\Z=.?+),35T?+-36EU-8WD-W;N4FA<2(P[
M$4^_L+G3+^>QNXS'<0.4=3Z_X56KTMS$^F?"'BZR\5:4D\3*EV@ G@)Y1O\
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MCW_H3I/U_P *TJ0<I-H2>AZ917F?_"8^/?\ H3I/U_PH_P"$Q\>_]"=)^O\
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@- "T4F:,T +129HS0 M%)FC- "T4F:,T +129HH _]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
